Embla Genomics ApS — Credit Rating and Financial Key Figures

CVR number: 41685603
Hallinsgade 30, 2100 København Ø

Income statement (kDKK)

2021
2022
2023
2024
Fiscal period length12121212
Net sales
Gross profit-10.01-9.21-8.26
Wages and salaries-35.17
Social security expenses-0.36-0.26-0.28
EBIT- 209.19-10.37-9.47-8.55
Other financial income0.00
Other financial expenses-2.92-0.44-1.12-1.20
Pre-tax profit- 212.12-10.81-10.59-9.75
Income taxes41.022.382.14
Net earnings- 171.10-8.43-10.59-7.60

Assets (kDKK)

2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables0.240.210.210.08
Current deferred tax assets41.0243.4043.4045.54
Short term receivables total41.2543.6143.6045.62
Cash and bank deposits27.6516.876.286.66
Cash and cash equivalents27.6516.876.286.66
Balance sheet total (assets)68.9060.4749.8852.28

Equity and liabilities (kDKK)

2021
2022
2023
2024
Share capital40.0040.0040.0040.00
Share premium account200.00200.00200.00
Other reserves200.00
Retained earnings- 171.10- 179.53- 190.12
Profit of the financial year- 171.10-8.43-10.59-7.60
Shareholders equity total68.9060.4749.8842.28
Non-current owed to group member10.00
Non-current liabilities total10.00
Current liabilities total
Balance sheet total (liabilities)68.9060.4749.8852.28
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.